Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors F Zerbib, A Duriez, S Roman, M.

Slides:



Advertisements
Similar presentations
Proton Pump Inhibitors
Advertisements

A 50-year-old man with a history of symptomatic gastroesophageal reflux disease (GERD) has Barrett’s esophagus diagnosed on upper endoscopy. Which of.
Gastroesophageal reflux Definition: Retrograde flow from stomach into oesophagus Does not have to present at mouth.
ESOPHAGEAL pH STUDIES IN ESOPHAGEAL DISEASE
GERD and Peptic ulcer disease
Figure 1. Higher prevalence of significant GER symptoms in patients with COPD. The prevalence of significant GER symptoms (heartburn and/or regurgitation.
1 Literature Review Peter R. McNally, DO, FACP, FACG Lone Tree, Colorado.
The Co-existence and Severity of Acid and Alkaline Reflux in Pediatric and Adult Patients with Eosinophilic Esophagitis Asif Shah University at Buffalo.
The Non-Medical Treatments of the Gastroesophageal Reflux Disease (GERD) Joint Hospital Grand Round Prepared by Siu Yin Yu, Eva North District.
New Developments in Gastroenterology at West Herts High Resolution oesophageal manometry and 24 hour pH studies Dr Mark Fullard Consultant Gastroenterologist.
DYSPHAGIA - THE ROLE OF OESOPHAGEAL MOTILITY DISORDERS IAN WALLACE FCP(SA), FRACP. SHAKESPEARE SPECIALIST GROUP MILFORD, AUCKLAND.
In patients with Gastroesophageal Reflux Disease is Esomeprazole the most efficient proton pump inhibitor to induce mucosal healing? Introdução à Medicina.
In patients with Gastroesophageal Reflux Disease is Esomeprazole the most effective proton pump inhibitor to induce mucosal healing and/or to maintain.
Refractory Heartburn: When PPI’s Fail to Sooth the Burn
Gastro-Esophageal Reflux Disease
Gastroesophageal Reflux Disease: Beyond Heartburn Annette Y. Kwon, M.D. Edward W. Holt, M.D. October 1, 2011.
Week 4 – Gastroenterology Clinical Pharmacy
Esophageal Problems after Gastric Banding
Hiatal Hernia Repair, Vagotomy, Gastrectomy for GERD
gastroesophageal reflux disease GERD
Routine Combined Esophageal Impedance and pH Measurement in Children T. G. Wenzl, M. Welter, E. Berkemeier, G. Heimann Kinderklinik, Universitätsklinikum.
Edward Auyang, MD, MS, FACS Assistant Professor of Surgery
New Techniques and Perspectives Presented on: May 17th 2014
A gastroenterologist’s view of GERD and its pre-operative workup
The ulcer of gastric stump: a case-control study Coordinators: Author: Roxana Spac Dr.Anca Negovan Drd. Monica Pantea Co-author: Dr Nina Sincu Andreea.
Diagnosis of PUD.
 Gastro-Oesophageal Reflux Disorder ● Present in around 10% of the population ● Symptoms or damage to the mucosal lining of the distal oesophagus ● Caused.
General Principles Of Treatment. Treatment Goals To relieve the symptoms of Benign (Peptic Stricture) To improve patient’s nutritional status.
DISEASES OF THE OESOPHAGUS BY Dr. ARWA M FUZI Lecture 1.
GASTRO-OESOPHAGEAL REFLUX DISEASE By Dr A S Maiyaki (FWACP) Gastroenterology Unit Department of Medicine Usmanu Danfodiyo University Teaching Hospital,
Gastro Esophageal Reflux Disease Presented for Sherman Hospital By Lawrence R. Kosinski, MD, MBA, FACG March 24 th, 2004.
Gastro Esophageal Reflux Disease (GERD)
Gastro-oesophageal reflux disease is the term used to describe a histopathological alteration resulting from episodes of reflux of acid, pepsin and occasionally.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Efficacy of Omeprazole for the Treatment of Symptomatic.
Gastro Oesophageo Reflux Disease (GORD) JMJ1. Contents Pathophysiology Oesophageo mucosal defense mechanisms Clinical features Diagnosis and investigations.
Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions FOOK–HONG NG, SIU–YIN WONG, KWOK–FAI LAM,
The Impact of Lifestyle Modification on the Health-Related Quality of Life of Patients With Reflux Esophagitis Receiving Treatment With a Proton Pump Inhibitor.
A Prospective Study to Compare a Symptom-Based Reflux Disease Questionnaire to 48-h Wireless pH Monitoring for the Identification of Gastroesophageal Reflux.
Diagnostic approach to GERD in child
Esophageal manometry and Gastroesophageal reflux testing
The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus The Prague C & M Criteria Gastroenterology 2006;131:1392~1399 This.
Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations  Taraq A. Attumi, MD, David Y. Graham, MD 
Baby with vomiting, when to worry
Ronnie Fass, MD. Professor of Medicine Case Western Reserve University
A prospective study of endoscopic radiofrequency application (STRETTA) for gastroesophageal reflux disease: Early UK experience N Hamza, D Kamali, S Punnoose,
Dr. Firas Obeidat,MD.
Pathophysiology Factors associated with development of GERD:
Refractory GERD Aaron Sinclair, MD
Contribution by: Prof. Dr. J.J. Kolkman
Figure 3 Algorithm from working group describing
داروهای کاهنده حرکت و ترشح
Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease  Evan S. Dellon, Nicholas J. Shaheen 
Can Proton Pump Inhibitor Deprescribing be Undertaken in a Scottish Community Pharmacy Setting? A Feasibility Study. Andrew Christopherson1,2, Alison H.
Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations  Taraq A. Attumi, MD, David Y. Graham, MD 
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Normal Values of Pharyngeal and Esophageal 24-Hour pH Impedance in Individuals on and off Therapy and Interobserver Reproducibility  Frank Zerbib, Sabine.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease  Evan S. Dellon, Nicholas J. Shaheen 
Management of Patients With Functional Heartburn
Figure 4 Examples of reflux episodes on pH and pH-impedance monitoring
Tracings of concurrent oesophageal manometry, pH, and impedance.
Ikuo Hirano, Qing Zhang, John E. Pandolfino, Peter J. Kahrilas 
Increased Prandial Air Swallowing and Postprandial Gas-Liquid Reflux Among Patients Refractory to Proton Pump Inhibitor Therapy  Ivana Bravi, Philip Woodland,
Radu Tutuian, Donald O Castell 
Volume 120, Issue 7, Pages (June 2001)
Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry 
Volume 143, Issue 3, Pages (September 2012)
GASTROESOPHAGEAL REFLUX DISEASE
Presentation transcript:

Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors F Zerbib, A Duriez, S Roman, M Capdepont, F Mion R3 임효석 Gut 2008;57:156–160

Background Approximately 30-40% of patients have persistent symptoms of gastro-oesophageal reflux despite proton pump inhibitor (PPI) therapy. Acid component of the refluxate : : a major role in the pathophysiology of gastro-oesophageal reflux disease (GORD) Ambulatory pH monitoring : temporal relationship between symptoms and reflux episodes.

Aim To assess the factors associated with the perception of gastro- oesophageal reflux episodes detected by means of ambulatory 24 h oesophageal pH–impedance monitoring. (On PPI)

Methods Patients 59 patients : : pH–impedance study because of persistent typical GORD (Regurgitation, heartburn) symptoms despite adequate PPI therapy. 39 patients were excluded : : negative symptom–reflux association (n=35) no symptom occurrence during the 24 h recording (n=4) 20 patients (14 women, mean age 44.6 years, range 18–77) with typical GORD symptoms were finally included in the study.

20 patients previously documented GORD by 1 ) endoscopy and/or pH study 2 ) persistent symptoms on PPI prescribed empirically for at least 2 weeks before the pH–impedance study. PPI prescribed (double dose) : twice-daily omeprazole 20 mg, lansoprazole 30 mg, rabeprazole 20 mg, pantoprazole 40 mg or esomeprazole 40 mg.

Study protocol - outpatients - outpatients - record pH at 5 cm and impedance at 3, 5, 7, 9, 15 and 17 cm - record pH at 5 cm and impedance at 3, 5, 7, 9, 15 and 17 cm proximal to the LOS. proximal to the LOS. Definitions of reflux episodes - Liquid reflux : retrograde 50% drop in impedance - Gas reflux : a rapid (3 kΩ/s) increase in impedance.5000 Ω occurring simultaneously at least in two oesophageal measuring segments,

GI Motility online (May 2006) | doi: /gimo31 Combined multichannel intraluminal impedance and pH catheter.

pHmetry (1) Acid reflux: oesophageal pH <4 (2) Weakly acidic reflux : oesophageal pH between 4 and 7 (3) Weakly alkaline reflux : reflux episodes during which nadir oesophageal pH does not drop below 7. Gastro-oesophageal reflux variables - upright and supine & symptomatic or not - composition (liquid or mixed liquid–gas) - chemical composition (acid, weakly acidic or weakly alkaline) - proximal reflux (reflux reaching the 15 cm impedance site) - median reflux bolus clearance time (determined 5 cm above the LOS) - bolus burden (cumulative oesophageal exposure to the bolus 1 h before the onset of the reflux episode) - number of preceding (1 h) acid and weakly acidic reflux episodes - acid clearance time, acid burden, nadir pH

Results Among the 20 patients included in this study, 6 reported regurgitation, 2 reported heartburn and 12 reported both symptoms. Endoscopy was normal in 14 patients, 2 - hiatal hernia without oesophagitis low grade oesophagitis 3 - short segment Barrett’s oesophagus

Table 1. Characteristics of symptomatic and asymptomatic reflux episodes in 20 patients with persisting symptoms on proton pump inhibitors High proximal extent : reflux reaching the 15 cm impedance site above the LOS (312)(961)

Figure 1. Rates of symptomatic and asymptomatic reflux events with high proximal extent in 20 patients with persisting symptoms on twice daily PPIs. Each white circle represents the percentage of reflux events with high proximal extent in an individual patient. The filled circles and associated lines are the median values for each group.

Table 2. Characteristics of 312 symptomatic reflux episodes in the supine and upright position in 20 patients with persisting symptoms on proton pump inhibitors

Table 3. Characteristics of reflux episodes associated with heartburn and regurgitation

Discussion Weakly acidic reflux episodes play a major role in eliciting symptoms in 30–40% of patients on PPI therapy.  double-dose PPIs High High proximal extent of the refluxate was the only factor associated with symptom perception. In patients off therapy, Bredenoord et al reported that not only higher proximal extent but also a larger pH drop, lower nadir pH and longer volume and acid clearance were associated with reflux perception.

In this study, the role of chemical composition of the refluxate may not be so relevant in patients with adequate acid-suppressive therapy. Reflux episodes eliciting heartburn were more frequently pure liquid and acidic, had a lower nadir pH and were more frequently associated with preceding acid reflux episodes.   the perception of heartburn is more sensitive to the chemical composition of the refluxate than regurgitation.

Conclusion The major role of proximal spread of reflux episodes as a determinant of perception in patients on PPI therapy. Compared with regurgitation, the chemical composition of the refluxate appears to be involved in the perception of heartburn. In patients with ‘‘refractory GORD’’, second intention antireflux therapies (eg, surgery, endoscopic procedures or drugs) should aim at not only reducing the number of reflux episodes but also limiting their proximal extent within the oesophagus.